BNP Paribas Exane Starts AstraZeneca (AZN) at Outperform
Tweet
Share
E-mailGet Alerts AZN Hot Sheet
Price: $92.77 --0%
Rating Summary:
19 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
19 Buy, 8 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BNP Paribas Exane initiates coverage on AstraZeneca (NASDAQ: AZN) with a Outperform rating and a price target of $75.00.
For an analyst ratings summary and ratings history on AstraZeneca click here. For more ratings news on AstraZeneca click here.
Shares of AstraZeneca closed at $68.01 yesterday.
You May Also Be Interested In
- Morgan Stanley analysts visit National Resilience facility in Ohio, clients include LLY and AZN
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- BMO Capital Starts Energy Fuels (UUUU) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
